AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
Abstract Pompe disease (PD) is a metabolic myopathy due to acid alpha-glucosidase deficiency and characterized by extensive glycogen storage and impaired autophagy. We previously showed that modulation of autophagy and lysosomal exocytosis by overexpression of the transcription factor EB (TFEB) gene...
Saved in:
Main Authors: | Francesca Gatto, Barbara Rossi, Antonietta Tarallo, Elena Polishchuk, Roman Polishchuk, Alessandra Carrella, Edoardo Nusco, Filomena Grazia Alvino, Francesca Iacobellis, Elvira De Leonibus, Alberto Auricchio, Graciana Diez-Roux, Andrea Ballabio, Giancarlo Parenti |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/678d39e7a19b43b9866916b4208c4792 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
by: Antonietta Tarallo, et al.
Published: (2021) -
mTOR-dependent phosphorylation controls TFEB nuclear export
by: Gennaro Napolitano, et al.
Published: (2018) -
Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
by: Véronique Roig-Zamboni, et al.
Published: (2017) -
Molecular study of Pompe disease in Egyptian infants
by: Mona Essawi, et al.
Published: (2021) -
TFEB regulates murine liver cell fate during development and regeneration
by: Nunzia Pastore, et al.
Published: (2020)